73
Views
8
CrossRef citations to date
0
Altmetric
Original Research

A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011

, , , , , , & show all
Pages 453-459 | Published online: 03 Oct 2013

References

  • The Japanese Respiratory SocietyGuidelines for the Diagnosis and Treatment of COPD3rd edTokyoJapanese Respiratory Society2009
  • LopezADShibuyaKRaoCChronic obstructive pulmonary disease: current burden and future projectionsEur Respir J20062739741216452599
  • MathersCDLoncarDProjections of global mortality and burden of disease from 2002 to 2030PLoS Med2006311e44217132052
  • Global initiative for chronic Obstructive Lung Disease (GOLD) [homepage on the Internet]2010 Available from: http://www.goldcopd.org/Guidelines/guideline-2010-gold-report.htmlAccessed March 25, 2013
  • Global initiative for chronic Obstructive Lung Disease (GOLD)2011http://www.goldcopd.org/Guidelines/guideline-2011-gold-report.htmlAccessed March 25, 2013
  • Global initiative for chronic Obstructive Lung Disease (GOLD)2013http://www.goldcopd.org/Guidelines/guideline-2013-gold-report.htmlAccessed March 25, 2013
  • JonesPWHardingGBerryPWiklundIChenWHKline LeidyNDevelopment and first validation of the COPD Assessment TestEur Respir J20093464865419720809
  • JonesPWBrusselleGDal NegroRWProperties of the COPD assessment test in a cross-sectional European studyEur Respir J201138293521565915
  • TsudaTSuematsuRKamoharaKDevelopment of the Japanese version of the COPD Assessment TestRespir Investig2012503439
  • IchinoseMAizawaHIshizakaA[Chronic obstructive pulmonary disease (COPD) burden in Japan: confronting COPD Japan survey.]Nihon Kokyuki Gakkai Zasshi20074512927935 Japanese [with English abstract]18186237
  • FukuchiYNishimuraMIchinoseMCOPD in Japan: the Nippon COPD Epidemiology studyRespirology2004945846515612956
  • NakanoYNagaiAMishimaMYoshimotoDHaganG[Investigation of COPD management in primary care in Japan using hand-held spirometer.]Kokyu201231273281 Japanese
  • AaronSDVandemheenKLFergussonDCanadian Thoracic Society/Canadian Respiratory Clinical Research ConsortiumTiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trialAnn Intern Med200714654555517310045
  • PerngDWWuCCSuKCLeeYCPerngRPTaoCWAdditive benefits of tiotropium in COPD patients treated with long-acting beta agonists and corticosteroidsRespirology20061159860216916333
  • SinghDBrooksJHaganGCahnAO’ConnorBJSuperiority of ‘triple’ therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPDThorax20086359259818245142
  • WelteTMiravitllesMHernandezPEfficacy and tolerability of budesonide/formoterol added to tiotropium in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med200918074175019644045
  • HananiaNACraterGDMorrisANEmmettAHO’DellDMNiewoehnerDEBenefits of adding fluticasone propionate/salmeterol to tiotropium in moderate to severe COPDRespir Med201210619110122040533
  • BestallJCPaulEAGarrodRGarnhamRJonesPWWedzichaJAUsefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary diseaseThorax19995458158610377201
  • GlaxoSmithKlineEvaluating the Control of COPD Symptoms in Patients Treated With Tiotropium Bromide 18mcg Once Daily Alone, ADOAIR 50/250mcg Twice Daily Alone or ADOAIR 50/250mcg Plus Tiotropium Bromide 18mcgClinicalTrials.gov [website on the Internet]Bethesda, MDUS National Library of Meicine2012 [updated July 11, 2013]. Available from: http://www.clinicaltrials.gov/ct2/show/NCT1762800?term=NCT1762800&rank=1. NLM identifier: NCT1762800Accessed August 28, 2013
  • LeidyNKWilcoxTKJonesPWRobertsLPowersJHSethiSEXACT-PRO Study GroupStandardizing measurement of chronic obstructive pulmonary disease exacerbations: reliability and validity of a patient-reported diaryAm J Respir Crit Care Med201118332332920813886
  • JonesPWChenWHWilcoxTKSethiSLeidyNKEXACT-PRO Study GroupCharacterizing and quantifying the symptomatic features of COPD exacerbationsChest201113961388139421071529
  • LeidyNKWilcoxTKJonesPWEXACT-PRO Study GroupDevelopment of the EXAcerbations of Chronic Obstructive Pulmonary Disease Tool (EXACT): a patient-reported outcome measureValue Health20101396597520659270
  • SchmierJKHalpernMTHigashiMKBakstAThe quality of life impact of acute exacerbations of chronic bronchitis (AECB): a literature reviewQual Life Res20051432934715892423
  • SinDDMcAlisterFAManSFAnthonisenNRContemporary management of chronic obstructive pulmonary disease: scientific reviewJAMA2003290172301231214600189
  • BahadoriKFitzGeraldJMRisk factors of hospitalization and readmission of patients with COPD exacerbation: a systematic reviewInt J Chron Obstruct Pulmon Dis2007224125118229562
  • VestboJAndersonJACalverleyPMBias due to withdrawal in long-term randomised trials in COPD: evidence from the TORCH studyClin Respir J20115444921159140
  • KeeneONVestboJAndersonJAMethods for therapeutic trials in COPD: lessons from the TORCH trialEur Respir J2009341018102319880616